Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 6841 AL 6855

Oxidative stress and neurodegenerative diseases: looking for a therapeutic solution inspired on benzopyran chemistry

Gaspar A, Milhazes N, Santana L, Uriarte E, Borges F, Matos MJ.

Curr Top Med Chem. 2015;15(5):432-45.

Is lithium a neuroprotective agent?

Vo TM, Perry P, Ellerby M, Bohnert K.

Ann Clin Psychiatry. 2015 Feb;27(1):49-54.

From Neurodegeneration to Brain Health: An Integrated Approach

Petersen RB, Lissemore FM, Appleby B, Aggarwal N, Boyatzis R, Casadesus G, Cummings J, Jack A, Perry G, Safar J, Sajatovic M, Surewicz WK, Wang Y, Whitehouse P, Lerner A.

J Alzheimers Dis. 2015;46(1):271-83. doi: 10.3233/JAD-150043.

[New therapeutic approaches]

Kurz A, Grimmer T.

Ther Umsch. 2015 Apr;72(4):279-85. doi: 10.1024/0040-5930/a000676.

Precision medicine: Clarity for the clinical and biological complexity of Alzheimer's and Parkinson's diseases

Montine TJ, Montine KS.

J Exp Med. 2015 May 4;212(5):601-5. doi: 10.1084/jem.20150656.

Ferulic acid and Alzheimer's disease: promises and pitfalls

Nabavi SF, Devi KP, Malar DS, Sureda A, Daglia M, Nabavi SM.

Mini Rev Med Chem. 2015;15(9):776-88. doi: 10.2174/1389557515666150522102545.

Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases

Fernández-Moriano C, González-Burgos E, Gómez-Serranillos MP.

Oxid Med Cell Longev. 2015;2015:408927. doi: 10.1155/2015/408927. Epub 2015 Apr 29.

Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Donohue MC, Green RC, Harvey D, Jack CR Jr, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw L, Thompson PM, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jul;11(7):865-84. doi: 10.1016/j.jalz.2015.04.005.

Trial design innovations: Clinical trials for treatment of neuropsychiatric symptoms in Alzheimer's Disease

Cummings J, Zhong K.

Clin Pharmacol Ther. 2015 Nov;98(5):483-5. doi: 10.1002/cpt.190. Epub 2015 Aug 31.

The Third French Alzheimer Plan: analysis of the influence of a national public health initiative on scientific research productivity and impact

Haeffner-Cavaillon N, Devos P, Ledoux S, Ménard J.

Alzheimers Res Ther. 2015 Sep 26;7(1):60. doi: 10.1186/s13195-015-0144-z.

Changes in Nutritional Status after Deep Brain Stimulation of the Nucleus Basalis of Meynert in Alzheimer's Disease--Results of a Phase I Study

Noreik M, Kuhn J, Hardenacke K, Lenartz D, Bauer A, Bührle CP, Häussermann P, Hellmich M, Klosterkötter J, Wiltfang J, Maarouf M, Freund HJ, Visser-Vandewalle V, Sturm V, Schulz RJ.

J Nutr Health Aging. 2015 Oct;19(8):812-8. doi: 10.1007/s12603-015-0595-8.

Potential of GABA-ergic cell therapy for schizophrenia, neuropathic pain, and Alzheimer's and Parkinson's diseases

Shetty AK, Bates A.

Brain Res. 2016 May 1;1638(Pt A):74-87. doi: 10.1016/j.brainres.2015.09.019. Epub 2015 Sep 28.

Purinergic receptors as potential therapeutic targets in Alzheimer's disease

Woods LT, Ajit D, Camden JM, Erb L, Weisman GA.

Neuropharmacology. 2016 May;104:169-79. doi: 10.1016/j.neuropharm.2015.10.031. Epub 2015 Oct 28.

Neuroethical implications of deep brain stimulation in degenerative disorders

Ovadia D, Bottini G.

Curr Opin Neurol. 2015 Dec;28(6):598-603. doi: 10.1097/WCO.0000000000000263.

Applications of Nanotechnology in Diagnostics and Therapeutics of Alzheimer's and Parkinson's Disease

Soursou G, Alexiou A, Ashraf GM, Siyal AA, Mushtaq G, Kamal MA.

Curr Drug Metab. 2015;16(8):705-12. doi: 10.2174/138920021608151107125049.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias